NYSE - Delayed Quote USD

agilon health, inc. (AGL)

Compare
3.6400 -0.2200 (-5.70%)
At close: September 25 at 4:00 PM EDT
3.6400 0.00 (0.00%)
Pre-Market: 4:07 AM EDT
Loading Chart for AGL
DELL
  • Previous Close 3.8600
  • Open 3.8500
  • Bid 3.0000 x 3200
  • Ask --
  • Day's Range 3.6300 - 3.8900
  • 52 Week Range 3.0700 - 20.3700
  • Volume 3,138,364
  • Avg. Volume 4,780,609
  • Market Cap (intraday) 1.498B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5400
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.17

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

www.agilonhealth.com

1,117

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AGL

View More

Performance Overview: AGL

Trailing total returns as of 9/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AGL
71.00%
S&P 500
19.97%

1-Year Return

AGL
80.25%
S&P 500
32.46%

3-Year Return

AGL
87.05%
S&P 500
28.43%

5-Year Return

AGL
87.12%
S&P 500
37.21%

Compare To: AGL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AGL

View More

Valuation Measures

Annual
As of 9/25/2024
  • Market Cap

    1.50B

  • Enterprise Value

    1.14B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.28

  • Price/Book (mrq)

    2.21

  • Enterprise Value/Revenue

    0.22

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.66%

  • Return on Assets (ttm)

    -6.95%

  • Return on Equity (ttm)

    -27.85%

  • Revenue (ttm)

    5.28B

  • Net Income Avi to Common (ttm)

    -216.54M

  • Diluted EPS (ttm)

    -0.5400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    401.11M

  • Total Debt/Equity (mrq)

    6.83%

  • Levered Free Cash Flow (ttm)

    -111.63M

Research Analysis: AGL

View More

Company Insights: AGL

Research Reports: AGL

View More

People Also Watch